Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Testing the Safety of CB-5339 in Patients With Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04372641
Recruitment Status : Withdrawn (Other - Clinical development of the agent has been discontinued)
First Posted : May 4, 2020
Last Update Posted : August 30, 2021
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : July 12, 2021
Actual Study Completion Date : July 12, 2021